Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2009, Article ID 963037, 8 pages
Research Article

A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma

Laboratory of Immuno-Oncology and Tumor Immunotherapy, Immunology Program, Faculty of Medicine and Health Sciences, University of Sherbrooke, Sherbrooke, QC, Canada J1H 5N4

Received 8 August 2009; Revised 21 December 2009; Accepted 29 December 2009

Academic Editor: Susan Chang

Copyright © 2009 Marie-Denise Poirier et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [4 citations]

The following is the list of published articles that have cited the current article.

  • Derek A. Wainwright, Mahua Dey, Alan Chang, and Maciej S. Lesniak, “Targeting tregs in malignant brain cancer: Overcoming IDO,” Frontiers in Immunology, vol. 4, no. MAY, 2013. View at Publisher · View at Google Scholar
  • Patrick C. Gedeon, Katherine A. Riccione, Peter E. Fecci, and John H. Sampson, “Antibody-based immunotherapy for malignant glioma,” Seminars in Oncology, 2014. View at Publisher · View at Google Scholar
  • Jennifer S. Sims, Timothy H. Ung, Justin A. Neira, Peter Canoll, and Jeffrey N. Bruce, “Biomarkers for glioma immunotherapy: the next generation,” Journal of Neuro-Oncology, 2015. View at Publisher · View at Google Scholar
  • M. Dey, A.L. Chang, J. Miska, J. Qiao, and M.S. Lesniak, “The Role of Regulatory T Cells and Indoleamine-2,3-dioxygenase in Brain Tumor Immunosuppression,” Translational Immunotherapy of Brain Tumors, pp. 33–61, 2017. View at Publisher · View at Google Scholar